1. Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension;Birkenhager;J Hypertens,1999
2. Clinical efficacy and safety profiles of AT1 receptor antagonists;Bakris;Cardiovasc Rev Rep,1999
3. Angiotensin II, type 1 receptor blockers;Burnier;Circulation,2001
4. A comparison of the angiotensin II antagonists valsartan and losartan in the treatment of essential hypertension;Hedner;Am J Hypertens,1999
5. Merck & Co Inc. Losartan potassium prescribing information. West Point, PA 19486, USA, April 1995